Lenovo Unveils Pioneering AI-Driven Devices at Lenovo Innovation World 2024

5.9.2024 17:00:00 CEST | Business Wire | Press release

Lenovo also announced that it has extended its partnership with Formula 1®

Lenovo™, a global leader in technology innovation, announced its latest advancements at Lenovo Innovation World 2024, unveiling a series of AI PC devices, including ThinkPad™, ThinkBook™, Yoga™, and IdeaPad™ laptops, designed to transform both enterprise and consumer user experiences.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240905372293/en/

(Photo: Business Wire)

AI PC Era

AI PCs are set to revolutionize computing as their relevance grows, with 60% of PCs shipped by 2027 anticipated to be AI-capable. Lenovo’s AI PCs are at the forefront of this transformation, leveraging natural interactions, personalized large language models, and advanced computing architectures. These innovations make computing more personal by tailoring experiences to individual users, more productive by enhancing workflow efficiency, and more protected by integrating robust security features into AI-driven systems.

"At Lenovo, we are committed to pushing the boundaries of innovation and bringing AI-powered technology to everyone. Our latest AI PCs, including the groundbreaking Aura Edition series, represent a significant leap forward in delivering highly personalized, productive, and protected computing experiences,” said Luca Rossi, President of Lenovo Intelligent Devices Group. “Through close collaboration with industry leaders, we are redefining what’s possible with AI, ensuring that our customers can harness the full potential of these transformative technologies to drive productivity, creativity, and growth in the AI era."

Powering Business Users in the AI Era

In the commercial segment for business users, Lenovo introduced the ThinkPad X1 Carbon Gen 13 Aura Edition, a cutting-edge business laptop co-developed with Intel. This device features Intel® Core™ Ultra technology, offering unparalleled AI capabilities and a user-centric design. The Lenovo Aura Edition series include innovative features such as Smart Modes, which intuitively adapt performance and AI capabilities to user activities, and Smart Share, enabling seamless AI-driven image sharing between devices. Smart Care provides 24/7 real-time support, ensuring users receive the assistance they need. With its advanced AI capabilities, the ThinkPad X1 Carbon Gen 13 Aura Edition redefines productivity, security, and user interaction in a lightweight, premium build.

Alongside it, Lenovo presented the ThinkPad T14s Gen 6 AMD and the ThinkBook 16 Gen 7+ powered by AMD Ryzen™ AI processors, showcasing exceptional multitasking, creative expression, and energy efficiency. Additionally, Lenovo revealed the ThinkBook 16 Gen 7, equipped with the Snapdragon® X Plus 8-core processor, bringing robust AI performance to small and medium-sized businesses.

Lenovo also announced AI PC Fast Start, a solution designed to help organizations swiftly transition to AI-ready devices, maximizing ROI through AI-powered advisory and simplified deployment. Backed by Lenovo's award-winning support, these services accelerate AI adoption and ensure seamless implementation.

Lenovo showcased the Lenovo Auto Twist AI PC, a proof-of-concept that redefines user interaction with intelligent automation and AI. This device features an industry-first auto-twist design, integrating AI-powered flexibility, smart interaction, and enhanced security to create a seamless and ergonomic computing experience.

Empowering Consumers with AI Technology

For consumers, Lenovo introduced several distinct laptops. The Lenovo Yoga Slim 7i Aura Edition (15”, 9), developed in collaboration with Intel, represents the pinnacle of premium design and innovative technology. This laptop includes the Lenovo Aura Edition range of features tailored to enhance user experience, including Smart Modes, Smart Share and Smart Care. Powered by Intel's Core Ultra processor with high-performance integrated graphics, and an optional 2.8K OLED touchscreen delivering stunning visuals, the laptop is designed for demanding tasks.

The LenovoYoga Pro 7 (14”, 9), powered by the AMD Ryzen AI 9 processor with 50 TOPS neural processing unit (NPU) performance, is tailored for content creators and professionals who demand powerful multitasking and creative capabilities. It comes equipped with Lenovo X Power features to improve performance and efficiency. The Yoga Pro 7 also features a 14.5” PureSight Pro OLED display with stunning color accuracy and sharpness, providing an immersive visual experience for design and media work.

The Lenovo IdeaPad Slim 5x (14”, 9) and IdeaPad 5x 2-in-1 (14”, 9) further expand Lenovo’s AI offerings for mainstream users, blending sleek design with powerful performance. These devices, powered by Snapdragon X Plus 8-core processors, offer enhanced AI-driven productivity and versatile form factors, making them suitable for a wide range of user needs.

Lenovo further expands its IdeaPad laptop portfolio with the IdeaPad Slim 5 15" and 13" models, both of which are powered by AMD Ryzen 7000 Series Processors. These laptops offer robust performance for multitasking and demanding applications, and feature high quality displays for creative work and media consumption. Both models boast sleek, ultra-thin, and light designs, making them ideal for professionals and students alike.

Lenovo also showcases the Lenovo Creator Zone, an AI-powered software suite with Stable Diffusion 3 model, that enables creators to use natural language and reference images to generate and edit visual content, streamlining the creative process. The suite is initially available on the Lenovo Yoga Pro 9i, with support for additional Lenovo Yoga devices to follow.

Global Retail Design Language

Lenovo’s product showcase illustrated its innovative new Global Retail Design Language, a strategic initiative designed to transform the customer experience across all physical retail formats. This new design language, shown through the tables in the showcase area at Lenovo Innovation World, accentuates a cohesive and immersive brand presence, ensuring uniformity and consistency in Lenovo's global retail operations.

Built on five core principles designed to echo Lenovo’s recognizable visual identity through a premium feel using natural and more sustainable materials that exhibit warm minimalism and emphasizes Lenovo’s ecosystem of innovative products. By transforming the customer journey with engaging environments, interactive touchpoints, and personalized service, Lenovo aims to create an inspiring and memorable experience for every customer who engage with Lenovo in retail locations.

Lenovo Becomes Global Partner of Formula 1^®

Lenovo is set to become Global Partner of Formula 1 starting in 2025, while Motorola will serve as Global Smartphone Partner. This multi-year renewal will see Lenovo continue to provide cutting-edge technology, including High-Performance Computing solutions, servers, and edge devices, to support F1’s operations both at the track and remotely. Lenovo will also be the title sponsor of two races per season and increase its trackside branding alongside Motorola. The partnership highlights Lenovo’s commitment to innovation and sustainability, with initiatives like Lenovo’s Asset Recovery Service contributing to F1’s sustainability goals. Together, Lenovo and F1 will explore next-generation technologies such as AI PCs, AI-enabled Motorola smartphones and AR/VR solutions, further enhancing the sport’s global reach and fan engagement.

Lenovo Innovation World 2024

For more information, visit Lenovo’s Innovation World homepage or reference the announcements below:

About Lenovo

Lenovo is a US$57 billion revenue global technology powerhouse, ranked #248 in the Fortune Global 500, and serving millions of customers every day in 180 markets. Focused on a bold vision to deliver Smarter Technology for All, Lenovo has built on its success as the world’s largest PC company with a full-stack portfolio of AI-enabled, AI-ready, and AI-optimized devices (PCs, workstations, smartphones, tablets), infrastructure (server, storage, edge, high performance computing and software defined infrastructure), software, solutions, and services. Lenovo’s continued investment in world-changing innovation is building a more equitable, trustworthy, and smarter future for everyone, everywhere. Lenovo is listed on the Hong Kong stock exchange under Lenovo Group Limited (HKSE: 992) (ADR: LNVGY). To find out more visit https://www.lenovo.com, and read about the latest news via our StoryHub.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240905372293/en/

Contacts

Adrian Horne, adrianhorne@lenovo.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release

Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom